Specific pharmacological and G
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
05 Mar 2024
05 Mar 2024
Historique:
received:
08
08
2022
accepted:
15
02
2024
medline:
6
3
2024
pubmed:
6
3
2024
entrez:
5
3
2024
Statut:
epublish
Résumé
G protein-coupled receptors (GPCRs) constitute the largest family of membrane proteins and are important drug targets. The discovery of drugs targeting these receptors and their G protein signaling properties are based on assays mainly performed with modified receptors expressed in heterologous cells. However, GPCR responses may differ in their native environment. Here, by using highly sensitive G
Identifiants
pubmed: 38443355
doi: 10.1038/s41467-024-46177-z
pii: 10.1038/s41467-024-46177-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1990Subventions
Organisme : Agence Nationale de la Recherche (French National Research Agency)
ID : 18-CE11-0004-01
Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : 32271198
Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : 2022YFA1302901
Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : 32330049
Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : 82320108021
Informations de copyright
© 2024. The Author(s).
Références
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schioth, H. B. & Gloriam, D. E. Trends in GPCR drug discovery: new agents, targets and indications. Nat. Rev. Drug Discov. 16, 829–842 (2017).
pmcid: 6882681
doi: 10.1038/nrd.2017.178
Wettschureck, N. & Offermanns, S. Mammalian G proteins and their cell type specific functions. Physiol. Rev. 85, 1159–1204 (2005).
doi: 10.1152/physrev.00003.2005
Heng, B. C., Aubel, D. & Fussenegger, M. An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. Biotechnol. Adv. 31, 1676–1694 (2013).
doi: 10.1016/j.biotechadv.2013.08.017
Sriram, K. & Insel, P. A. G protein-coupled receptors as targets for approved drugs: how many targets and how many drugs? Mol. Pharmacol. 93, 251–258 (2018).
pmcid: 5820538
doi: 10.1124/mol.117.111062
Inoue, A. et al. Illuminating G-protein-coupling selectivity of GPCRs. Cell 177, 1933–1947 e1925 (2019).
pmcid: 6773469
doi: 10.1016/j.cell.2019.04.044
Hauser, A. S. et al. Common coupling map advances GPCR-G protein selectivity. eLife 11, e74107 (2022).
pmcid: 9005189
doi: 10.7554/eLife.74107
Avet, C. et al. Effector membrane translocation biosensors reveal G protein and beta arrestin coupling profiles of 100 therapeutically relevant GPCRs. eLife 11, e74101 (2022).
pmcid: 9005190
doi: 10.7554/eLife.74101
Okashah, N. et al. Variable G protein determinants of GPCR coupling selectivity. Proc. Natl Acad. Sci. USA 116, 12054–12059 (2019).
pmcid: 6575158
doi: 10.1073/pnas.1905993116
Kenakin, T. Biased receptor signaling in drug discovery. Pharmacol. Rev. 71, 267–315 (2019).
doi: 10.1124/pr.118.016790
Galandrin, S., Oligny-Longpre, G. & Bouvier, M. The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol. Sci. 28, 423–430 (2007).
doi: 10.1016/j.tips.2007.06.005
Kolb, P. et al. Community guidelines for GPCR ligand bias: IUPHAR review 32. Br. J. Pharmacol. 179, 3651–3674 (2022).
doi: 10.1111/bph.15811
Busnelli, M. et al. Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes. J. Biol. Chem. 287, 3617–3629 (2012).
doi: 10.1074/jbc.M111.277178
Masuho, I. et al. Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors. Sci. Signal. 8, ra123 (2015).
pmcid: 4886239
doi: 10.1126/scisignal.aab4068
Tran, K. et al. Size-reduced macrocyclic analogues of [Pyr(1)]-apelin-13 showing negative Galpha12 bias still produce prolonged cardiac effects. J. Med. Chem. 65, 531–551 (2022).
doi: 10.1021/acs.jmedchem.1c01708
Rosenbaum, M. I., Clemmensen, L. S., Bredt, D. S., Bettler, B. & Stromgaard, K. Targeting receptor complexes: a new dimension in drug discovery. Nat. Rev. Drug Discov. 19, 884–901 (2020).
doi: 10.1038/s41573-020-0086-4
Wingler, L. M. & Lefkowitz, R. J. Conformational basis of G protein-coupled receptor signaling versatility. Trends Cell. Biol. 30, 736–747 (2020).
pmcid: 7483927
doi: 10.1016/j.tcb.2020.06.002
Zhang, R. & Xie, X. Tools for GPCR drug discovery. Acta Pharmacol. Sin. 33, 372–384 (2012).
pmcid: 3312097
doi: 10.1038/aps.2011.173
Kenakin, T. Drug efficacy at G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 42, 349–379 (2002).
doi: 10.1146/annurev.pharmtox.42.091401.113012
Milligan, G. Principles: extending the utility of [35S]GTP gamma S binding assays. Trends Pharmacol. Sci. 24, 87–90 (2003).
doi: 10.1016/S0165-6147(02)00027-5
Strange, P. G. Use of the GTPgammaS ([35S]GTPgammaS and Eu-GTPgammaS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors. Br. J. Pharmacol. 161, 1238–1249 (2010).
pmcid: 3000650
doi: 10.1111/j.1476-5381.2010.00963.x
Mannoury la Cour, C., Herbelles, C., Pasteau, V., de Nanteuil, G. & Millan, M. J. Influence of positive allosteric modulators on GABA(B) receptor coupling in rat brain: a scintillation proximity assay characterisation of G protein subtypes. J. Neurochem. 105, 308–323 (2008).
doi: 10.1111/j.1471-4159.2007.05131.x
Maziarz, M. et al. Revealing the activity of trimeric G-proteins in live cells with a versatile biosensor design. Cell 182, 770–785 e716 (2020).
pmcid: 7415655
doi: 10.1016/j.cell.2020.06.020
Bunemann, M., Frank, M. & Lohse, M. J. Gi protein activation in intact cells involves subunit rearrangement rather than dissociation. Proc. Natl Acad. Sci. USA 100, 16077–16082 (2003).
pmcid: 307695
doi: 10.1073/pnas.2536719100
Gales, C. et al. Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat. Struct. Mol. Biol. 13, 778–786 (2006).
doi: 10.1038/nsmb1134
Olsen, R. H. J. et al. TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat. Chem. Biol. 16, 841–849 (2020).
pmcid: 7648517
doi: 10.1038/s41589-020-0535-8
Wright, S. C. & Bouvier, M. Illuminating the complexity of GPCR pathway selectivity - advances in biosensor development. Cur. Opin. Struct. Biol. 69, 142–149 (2021).
doi: 10.1016/j.sbi.2021.04.006
Hyman, S. E. Neurotransmitters. Cur. Biol. 15, R154–R158 (2005).
doi: 10.1016/j.cub.2005.02.037
Robishaw, J. D. & Berlot, C. H. Translating G protein subunit diversity into functional specificity. Cur. Opin. Cell. Biol. 16, 206–209 (2004).
doi: 10.1016/j.ceb.2004.02.007
Busnelli, M., Peverelli, E., Mantovani, G., Spada, A. & Chini, B. Deciphering the specific role of G(alphai/o) isoforms: functional selective oxytocin ligands and somatostatin SST5 receptor mutants. Biochem. Soc. Trans. 41, 166–171 (2013).
doi: 10.1042/BST20120306
Gassmann, M. & Bettler, B. Regulation of neuronal GABA(B) receptor functions by subunit composition. Nat. Rev. Neurosci. 13, 380–394 (2012).
doi: 10.1038/nrn3249
Saunders, C. & Limbird, L. E. Localization and trafficking of alpha2-adrenergic receptor subtypes in cells and tissues. Pharmacol. Ther. 84, 193–205 (1999).
doi: 10.1016/S0163-7258(99)00032-7
Langer, S. Z. alpha2-Adrenoceptors in the treatment of major neuropsychiatric disorders. Trends Pharmacol. Sci. 36, 196–202 (2015).
doi: 10.1016/j.tips.2015.02.006
Howlett, A. C. et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54, 161–202 (2002).
doi: 10.1124/pr.54.2.161
Contestabile, A. Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro. Cerebellum 1, 41–55 (2002).
doi: 10.1080/147342202753203087
England, C. G., Ehlerding, E. B. & Cai, W. NanoLuc: A small luciferase is brightening up the field of bioluminescence. Bioconjug. Chem. 27, 1175–1187 (2016).
pmcid: 4871753
doi: 10.1021/acs.bioconjchem.6b00112
Schihada, H., Shekhani, R. & Schulte, G. Quantitative assessment of constitutive G protein-coupled receptor activity with BRET-based G protein biosensors. Sci. Signal. 14, eabf1653 (2021).
doi: 10.1126/scisignal.abf1653
Jiang, M. & Bajpayee, N. S. Molecular mechanisms of Go signaling. Neurosignals 17, 23–41 (2009).
pmcid: 2836949
doi: 10.1159/000186688
Bettler, B., Kaupmann, K., Mosbacher, J. & Gassmann, M. Molecular structure and physiological functions of GABA(B) receptors. Physiol. Rev. 84, 835–867 (2004).
doi: 10.1152/physrev.00036.2003
Tu, H. et al. GABA
pmcid: 6633015
doi: 10.1523/JNEUROSCI.2343-09.2010
Ramachandran, S. & Cerione, R. A. A dominant-negative Galpha mutant that traps a stable rhodopsin-Galpha-GTP-betagamma complex. J. Biol. Chem. 286, 12702–12711 (2011).
pmcid: 3069470
doi: 10.1074/jbc.M110.166538
Liu, P. et al. The structural basis of the dominant negative phenotype of the Galphai1beta1gamma2 G203A/A326S heterotrimer. Acta Pharmacol. Sin. 37, 1259–1272 (2016).
pmcid: 5022103
doi: 10.1038/aps.2016.69
Ango, F. et al. A simple method to transfer plasmid DNA into neuronal primary cultures: functional expression of the mGlu5 receptor in cerebellar granule cells. Neuropharmacology 38, 793–803 (1999).
doi: 10.1016/S0028-3908(99)00005-2
Urwyler, S. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives. Pharmacol. Rev. 63, 59–126 (2011).
doi: 10.1124/pr.109.002501
Filip, M. et al. GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators. Neuropharmacology 88, 36–47 (2015).
doi: 10.1016/j.neuropharm.2014.06.016
Pin, J. P. & Prezeau, L. Allosteric modulators of GABA(B) receptors: mechanism of action and therapeutic perspective. Cur. Neuropharmacol. 5, 195–201 (2007).
doi: 10.2174/157015907781695919
Mao, C. et al. Cryo-EM structures of inactive and active GABAB receptor. Cell. Res. 30, 564–573 (2020).
pmcid: 7343782
doi: 10.1038/s41422-020-0350-5
Shen, C. et al. Structural basis of GABA
pmcid: 8222003
doi: 10.1038/s41586-021-03507-1
Liu, L. et al. Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface. eLife 10, e70188 (2021).
pmcid: 8700296
doi: 10.7554/eLife.70188
Lecat-Guillet, N. et al. FRET-based sensors unravel activation and allosteric modulation of the GABA
doi: 10.1016/j.chembiol.2017.02.011
Berg, K. A. & Clarke, W. P. Making sense of pharmacology: inverse agonism and functional Selectivity. Int. J. Neuropsychopharmacol. 21, 962–977 (2018).
pmcid: 6165953
doi: 10.1093/ijnp/pyy071
Grunewald, S. et al. Importance of the gamma-aminobutyric acid(B) receptor C-termini for G-protein coupling. Mol. Pharmacol. 61, 1070–1080 (2002).
doi: 10.1124/mol.61.5.1070
Rajalu, M. et al. Pharmacological characterization of GABA
doi: 10.1016/j.neuropharm.2014.08.020
Shaye, H. et al. Structural basis of the activation of a metabotropic GABA receptor. Nature 584, 298–303 (2020).
pmcid: 8020835
doi: 10.1038/s41586-020-2408-4
Papasergi-Scott, M. M. et al. Structures of metabotropic GABA
pmcid: 7429364
doi: 10.1038/s41586-020-2469-4
Park, J. et al. Structure of human GABA
pmcid: 7725281
doi: 10.1038/s41586-020-2452-0
Vuillaume, M. L. et al. A novel mutation in the transmembrane 6 domain of GABBR2 leads to a Rett-like phenotype. Ann. Neurol. 83, 437–439 (2018).
doi: 10.1002/ana.25155
Onaivi, E. S. et al. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann. N. Y. Acad. Sci. 1074, 514–536 (2006).
doi: 10.1196/annals.1369.052
Burke, J. & Schwartz, M. Preclinical evaluation of brimonidine. Surv. Ophthalmol. 41, S9–S18 (1996).
doi: 10.1016/S0039-6257(96)82027-3
Mierau, J. et al. Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors. Eur. J. Pharmacol. 290, 29–36 (1995).
doi: 10.1016/0922-4106(95)90013-6
Goadsby, P. J. & Hoskin, K. L. Differential effects of low dose CP122,288 and eletriptan on Fos expression due to stimulation of the superior sagittal sinus in cat. Pain 82, 15–22 (1999).
doi: 10.1016/S0304-3959(99)00025-1
Manuel, I., Lombardero, L., LaFerla, F. M., Giménez-Llort, L. & Rodríguez-Puertas, R. Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease. Neuroscience 329, 284–293 (2016).
doi: 10.1016/j.neuroscience.2016.05.012
Maurel, B., Le Digarcher, A., Dantec, C. & Journot, L. Genome-wide profiling of G protein-coupled receptors in cerebellar granule neurons using high-throughput, real-time PCR. BMC Genomics. 12, 241 (2011).
pmcid: 3111393
doi: 10.1186/1471-2164-12-241
Jasper, J. R. et al. Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding. Biochem. Pharmacol. 55, 1035–1043 (1998).
doi: 10.1016/S0006-2952(97)00631-X
Robishaw, J. D. Preferential assembly of G-alphabetagamma complexes directed by the gamma subunits. Subcell. Biochem. 63, 181–191 (2012).
doi: 10.1007/978-94-007-4765-4_10
Masuho, I., Skamangas, N. K., Muntean, B. S. & Martemyanov, K. A. Diversity of the Gbetagamma complexes defines spatial and temporal bias of GPCR signaling. Cell Syst. 12, 324–337 e325 (2021).
pmcid: 8068604
doi: 10.1016/j.cels.2021.02.001
Kankanamge, D., Tennakoon, M., Karunarathne, A. & Gautam, N. G protein gamma subunit, a hidden master regulator of GPCR signaling. J. Biol. Chem. 298, 102618 (2022).
pmcid: 9678972
doi: 10.1016/j.jbc.2022.102618
Frank, M., Thumer, L., Lohse, M. J. & Bunemann, M. G Protein activation without subunit dissociation depends on a Galpha(i)-specific region. J. Biol. Chem. 280, 24584–24590 (2005).
doi: 10.1074/jbc.M414630200
Digby, G. J., Lober, R. M., Sethi, P. R. & Lambert, N. A. Some G protein heterotrimers physically dissociate in living cells. Proc. Natl Acad. Sci. USA 103, 17789–17794 (2006).
pmcid: 1693825
doi: 10.1073/pnas.0607116103
Pin, J. P. & Bettler, B. Organization and functions of mGlu and GABA
doi: 10.1038/nature20566
Dinamarca, M. C. et al. Complex formation of APP with GABA
pmcid: 6430795
doi: 10.1038/s41467-019-09164-3
Rice, H. C. et al. Secreted amyloid-beta precursor protein functions as a GABABR1a ligand to modulate synaptic transmission. Science 363, eaao4827 (2019).
pmcid: 6366617
doi: 10.1126/science.aao4827
Hanack, C. et al. GABA blocks pathological but not acute TRPV1 pain signals. Cell 160, 759–770 (2015).
doi: 10.1016/j.cell.2015.01.022
Schwenk, J. et al. Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits. Nature 465, 231–235 (2010).
doi: 10.1038/nature08964
Von Moo, E. et al. Ligand-directed bias of G protein signaling at the dopamine D2 receptor. Cell. Chem. Biol. 29, 226–238 e224 (2022).
doi: 10.1016/j.chembiol.2021.07.004
Peverelli, E. et al. Specific roles of G(i) protein family members revealed by dissecting SST5 coupling in human pituitary cells. J. Cell. Sci. 126, 638–644 (2013).
doi: 10.1242/jcs.116434
Melvin, L. S. et al. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs. Mol. Pharmacol. 44, 1008–1015 (1993).
Felder, C. C. et al. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol. Pharmacol. 48, 443–450 (1995).
Klein Herenbrink, C. et al. The role of kinetic context in apparent biased agonism at GPCRs. Nat. Commun. 7, 10842 (2016).
pmcid: 4770093
doi: 10.1038/ncomms10842
Suomivuori, C. M. et al. Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor. Science 367, 881–887 (2020).
pmcid: 7259329
doi: 10.1126/science.aaz0326
Kaupmann, K. et al. Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature 386, 239–246 (1997).
doi: 10.1038/386239a0
Galvez, T. et al. Ca(2+) requirement for high-affinity gamma-aminobutyric acid (GABA) binding at GABA(B) receptors: involvement of serine 269 of the GABA(B)R1 subunit. Mol. Pharmacol. 57, 419–426 (2000).
doi: 10.1124/mol.57.3.419
Bockaert, J., Perroy, J. & Ango, F. The complex formed by group I metabotropic Glutamate Receptor (mGluR) and Homer1a plays a central role in metaplasticity and homeostatic synaptic scaling. J. Neurosci. 41, 5567–5578 (2021).
pmcid: 8244974
doi: 10.1523/JNEUROSCI.0026-21.2021
Chavez-Abiega, S., Gronloh, M. L. B., Gadella, T. W. J., Bruggeman, F. J. & Goedhart, J. Single cell imaging of ERK and Akt activation dynamics and heterogeneity induced by G protein-coupled receptors. J. Cell. Sci. 135, jcs259685 (2022).
pmcid: 8977056
doi: 10.1242/jcs.259685
Sebastianutto, I. et al. D1-mGlu5 heteromers mediate noncanonical dopamine signaling in Parkinson’s disease. J. Clin. Invest. 130, 1168–1184 (2020).
pmcid: 7269571
doi: 10.1172/JCI126361
Goyet, E., Bouquier, N., Ollendorff, V. & Perroy, J. Fast and high resolution single-cell BRET imaging. Sci. Rep. 6, 28231 (2016).
pmcid: 4908377
doi: 10.1038/srep28231
Hauser, A. S. et al. Pharmacogenomics of GPCR Drug Targets. Cell 172, 41–54 e19 (2018).
pmcid: 5766829
doi: 10.1016/j.cell.2017.11.033
Zhang, B. et al. Environmental temperature differentially modulates C. elegans longevity through a thermosensitive TRP channel. Cell. Rep. 11, 1414–1424 (2015).
pmcid: 4758836
doi: 10.1016/j.celrep.2015.04.066
Doi, M. et al. Gpr176 is a Gz-linked orphan G-protein-coupled receptor that sets the pace of circadian behaviour. Nat. Commun. 7, 10583 (2016).
pmcid: 4757782
doi: 10.1038/ncomms10583
Liu, H. et al. Illuminating the allosteric modulation of the calcium-sensing receptor. Proc. Natl Acad. Sci. USA 117, 21711–21722 (2020).
pmcid: 7474691
doi: 10.1073/pnas.1922231117